Application | Comment | Organism |
---|---|---|
medicine | Cat-S or PAR2 inhibition might be a strategy to prevent microvascular disease in diabetes and other diseases | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | generation of siRNA Cat-S knockout mice | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
RO5461111 | - |
Homo sapiens | |
RO5461111 | inhibits Cat-S activity and reduces podocyte loss, proteinuria, glomerulosclerosis, and renal inflammation in T2D db/db mice | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
protease-activated receptor-2 + H2O | Mus musculus | - |
? | - |
? | |
protease-activated receptor-2 + H2O | Homo sapiens | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P25774 | - |
- |
Mus musculus | O70370 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
endothelial cell | - |
Mus musculus | - |
endothelial cell | - |
Homo sapiens | - |
glomerular endothelial cell | GEnC | Homo sapiens | - |
kidney | - |
Mus musculus | - |
kidney | - |
Homo sapiens | - |
macrophage | cathepsin S is expressed by macrophages infiltrating the human kidney | Homo sapiens | - |
additional information | in human type 2 diabetic nephropathy, only CD68+ intrarenal monocytes express Cat-S mRNA, whereasCat-S protein is present along endothelial cells and inside proximal tubular epithelial cells also | Homo sapiens | - |
additional information | in mouse type 2 diabetic nephropathy, only CD68+ intrarenal monocytes express Cat-S mRNA, whereasCat-S protein is present along endothelial cells and inside proximal tubular epithelial cells also. Transcriptome analysis | Mus musculus | - |
podocyte | - |
Mus musculus | - |
podocyte | - |
Homo sapiens | - |
proximal tubular epithelial cell | - |
Mus musculus | - |
proximal tubular epithelial cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
protease-activated receptor-2 + H2O | - |
Mus musculus | ? | - |
? | |
protease-activated receptor-2 + H2O | - |
Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Cat-S | - |
Mus musculus |
Cat-S | - |
Homo sapiens |
CTSS | - |
Mus musculus |
CTSS | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | in vitro transcriptome analysis and experiments using siRNA or specific Cat-S and PAR2 antagonists revealed that Cat-S specifically impaired the integrity and barrier function of glomerular endothelial cells selectively through PAR2 | Mus musculus |
malfunction | in vitro transcriptome analysis and experiments using siRNA or specific Cat-S and PAR2 antagonists revealed that Cat-S specifically impaired the integrity and barrier function of glomerular endothelial cells selectively through PAR2. Extrinsic and intrinsic Cat-S triggers endothelial cell injury and microvascular permeability through PAR2 in vivo. Cat-S-induced monolayer disruption is prevented by Cat-S. Extrinsic and intrinsic Cat-S triggers endothelial cell injury and microvascular permeability through PAR2 in vivo | Homo sapiens |
physiological function | cathepsin S (Cat-S) is a cysteine protease that degrades elastic fibers and activates the protease-activated receptor-2 (PAR2) on endothelial cells. Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications. Cat-S is a monocyte/macrophage-derived circulating PAR2 agonist and mediator of endothelial dysfunction-related microvascular diabetes complications. Extrinsic and intrinsic Cat-S triggers endothelial cell injury and microvascular permeability through PAR2 in vivo, Cat-S specifically induces GEnC dysfunction through PAR2 in vitro | Homo sapiens |
physiological function | cathepsin S (Cat-S) is a cysteine protease that degrades elastic fibers and activates the protease-activated receptor-2 (PAR2) on endothelial cells. Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications. Cat-S is a monocyte/macrophage-derived circulating PAR2 agonist and mediator of endothelial dysfunction-related microvascular diabetes complications. In vitro transcriptome analysis and experiments using siRNA or specific Cat-S and PAR2 antagonists revealed that Cat-S specifically impaired the integrity and barrier function of glomerular endothelial cells selectively through PAR2. Delayed treatment of type 2 diabetic db/db mice with Cat-S or PAR2 inhibitors attenuates albuminuria and glomerulosclerosis (indicators of diabetic nephropathy) and attenuates albumin leakage into the retina and other structural markers of diabetic retinopathy | Mus musculus |